Abstract
CD19/CD22 chimeric antigen receptor (CAR) T-cell cocktail therapy following autologous transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma on 18 F-FDG PET/CT: a case description
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have